Nortian produces ultra-pure collagen from hides using a proprietary, vertically integrated process designed for supplements, food, beauty, and pharmaceutical applications. Its collagen achieves approximately 99% purity and about 98% protein concentration. The company plans to activate a U.S. manufacturing hub in St. Joseph, Missouri — a 90,000 sq. ft. facility on a 24-acre site with initial capacity of 600 tons per month and plans to scale to 1,000 tons per month — creating 138 new jobs. Nortian emphasizes a U.S.-first strategy to address heavy import reliance and take advantage of tariffs, incentives, and rising demand for local manufacturing. The company raised $41 million to launch U.S. manufacturing and accelerate commercialization and now has a reported $100 million post-money valuation. Founded in 2024, Nortian's leadership includes industry veterans and alumni from Morgan Stanley, UBS, and leading biotech companies, and its founder has a track record building and exiting ingredient and contract-manufacturing businesses.

Total raised

$41M

Funding rounds

1

Latest round

Equity

Latest activity

May 2025